MacuLogix focuses on detecting and tracking age-related macular degeneration. The Company offers AdaptDx, a sensitive functional test which measures dark adaptation, which is dramatically impaired at the earliest stages of AMD, RP and other macular degenerations. MacuLogix's test helps practices discover disease earlier and prompts the use of other diagnostic equipment.